Indacaterol is an ultra-long-acting β2-adrenergic agonist used in the maintenance treatment of chronic obstructive pulmonary disease (COPD) to improve airflow by inducing bronchodilation. In pharmaceutical… Read more




































Indacaterol is an ultra-long-acting β2-adrenergic agonist used in the maintenance treatment of chronic obstructive pulmonary disease (COPD) to improve airflow by inducing bronchodilation. In pharmaceutical development and quality control, laboratories rely on high-quality reference standards for Indacaterol to ensure therapeutic efficacy and regulatory compliance. This category includes a comprehensive range of these essential materials, such as pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, and degradation products that may arise during drug formulation or storage. By utilizing these reference standards for impurity profiling and analytical method validation, researchers can accurately identify and quantify related substances. Additionally, the availability of stable isotope labelled compounds facilitates precise bioanalytical quantification and stability studies, supporting the stringent quality standards required for the production and assessment of this bronchodilator in various dosage forms.